AA
PACB icon

Ancora Advisors’s Pacific Biosciences PACB Stock Holding History

Ancora Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$722 Hold
430
– – ﹤0.01% 1879
2026
Q1 		$568 Hold
430
– – ﹤0.01% 2280
2025
Q4 		$804 Hold
430
– – ﹤0.01% 2256
2025
Q3 		$550 Hold
430
– – ﹤0.01% 1823
2025
Q2 		$533 Buy
+430
New +$497 ﹤0.01% 1824
2023
Q2 		– Sell
-50
Closed -$579 – 1881
2023
Q1 		$579 Buy
+50
New +$497 ﹤0.01% 1707

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Ancora Advisors's PACB Position: Q2 2026 in Review

Ancora Advisors held its Pacific Biosciences (PACB) position steady in Q2 2026 at 430 shares worth $722. The position accounts for ﹤0.01% of the portfolio, ranked #1879.

Ancora Advisors first reported a position in PACB in Q1 2023 and has held it in 6 quarters since. The position peaked at $804 in Q4 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Ancora Advisors held 430 shares of Pacific Biosciences worth $722 as of Q2 2026.
  • Ancora Advisors left its Pacific Biosciences share count unchanged in Q2 2026.
  • Pacific Biosciences made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1879 holding.
  • Ancora Advisors first reported a position in Pacific Biosciences in Q1 2023 and has held it in 6 quarters since.
  • Ancora Advisors's Pacific Biosciences position peaked at $804 in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.